Skip to main content
. 2011 Apr 3;32(6):876–881. doi: 10.1093/carcin/bgr058

Table III.

HRs for incident HCC by metabolic factors assayed at baseline

Metabolic factors HCC (n=124)
Non-cases (n=1018)
HRa 95% CI P for trend
No. (%) No. (%)
Fasting insulin levels, μU/ml
    Category cutpoints 0.0140
        <2.75 41 (33.1) 354 (34.8) 1.57 (0.96–2.58)
        2.75–4.10 16 (12.9) 249 (24.5) 1 (Ref)
        4.11–6.10 29 (23.4) 230 (22.6) 1.28 (0.76–2.15)
        >6.10 38 (30.6) 185 (18.2) 2.36 (1.43–3.90)
    Quartile cutpoints 0.0556
        <2.27 32 (25.8) 250 (24.6) 1.43 (0.89–2.30)
        2.27–3.60 21 (16.9) 266 (26.1) 1 (Ref)
        3.61–5.36 26 (21.0) 263 (25.8) 0.95 (0.58–1.56)
        >5.36 45 (36.3) 239 (23.5) 1.78 (1.15–2.75)
Fasting glucose levels, mg/dl 0.0161
    <110 108 (87.1) 955 (93.8) 1 (Ref)
    110–125 11 (8.9) 43 (4.2) 1.40 (0.80–2.45)
    ≥126 5 (4.0) 20 (2.0) 2.37 (1.12–5.04)
History of diabetes by questionnaire
    No 116 (93.5) 995 (97.7) 1 (Ref)
    Yes 8 (6.5) 23 (2.3) 2.11 (1.13–3.94) 0.0192b
IR (HOMA-IR)
    Category cutpoints 0.0382
        <0.70 48 (38.7) 459 (45.1) 1.30 (0.82–2.08)
        0.70–1.02 19 (15.3) 229 (22.5) 1 (Ref)
        1.03–1.53 26 (21.0) 190 (18.7) 1.20 (0.73–1.98)
        >1.53 31 (25.0) 140 (13.8) 1.97 (1.20–3.22)
    Quartile cutpoints 0.0175
        <0.46 31 (25.0) 250 (24.6) 1.48 (0.90–2.44)
        0.46–0.77 20 (16.1) 270 (26.5) 1 (Ref)
        0.78–1.22 23 (18.5) 262 (25.7) 0.92 (0.54–1.55)
        >1.22 50 (40.3) 236 (23.2) 1.96 (1.23–3.10)
BMI ≥25 kg/m2
    No 75 (60.5) 716 (70.3) 1 (Ref)
    Yes 49 (39.5) 302 (29.7) 1.58 (1.16–2.17) 0.0041b
a

HR and 95% CIs were adjusted for number of visits, age (continuous), smoking, alcohol consumption, a first-degree family history of HCC and baseline viral factors, including HBV viral load (continuous), genotype (C versus non-C), HBeAg status and the BCP double mutations.

b

P values were obtained by the Wald test.